Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Citrated: K, KH, RTH, FFH

K-Number: K232018 · 2024-03-29

Decision Date2024-03-29
Product CodeJPA
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

Citrated: K, KH, RTH, FFH is a medical device manufactured by Haemonetics Corporation. It received FDA 510(k) clearance on 2024-03-29 under approval number K232018. The device is classified under product code JPA. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Citrated: K, KH, RTH, FFH?

Citrated: K, KH, RTH, FFH is a medical device that received FDA 510(k) clearance on 2024-03-29. It is manufactured by Haemonetics Corporation. The 510(k) number is K232018.

When was Citrated: K, KH, RTH, FFH approved by the FDA?

Citrated: K, KH, RTH, FFH received FDA 510(k) clearance on 2024-03-29, under approval number K232018.

What company makes Citrated: K, KH, RTH, FFH?

Citrated: K, KH, RTH, FFH is manufactured by Haemonetics Corporation.

What is the FDA product code for Citrated: K, KH, RTH, FFH?

The FDA product code for Citrated: K, KH, RTH, FFH is JPA.

Other Devices by Haemonetics Corporation

View all 7 devices →

Related Devices (Code: JPA)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.